Egrifta (Tesamorelin)
Complete Egrifta (Tesamorelin) Protocol & Tracking Guide
Egrifta is the brand name for tesamorelin — FDA-approved for HIV-associated lipodystrophy. Reduces visceral adipose tissue by stimulating GH release. 2mg subcutaneous daily injection.
🔬 Research✨ Free✓ Updated 2026
Overview
Egrifta is the brand name for tesamorelin — FDA-approved for HIV-associated lipodystrophy. Reduces visceral adipose tissue by stimulating GH release. 2mg subcutaneous daily injection.
Track with Shotlee
Log your doses, monitor effects, and optimize your protocol with data — completely free.
Get Shotlee Free